Better Therapeutics (BTTX) Stock Statistics & Valuation Metrics

Better Therapeutics has a market cap or net worth of $5.43K. The enterprise value is $21.80.

Better Therapeutics has 54,352,497 shares outstanding. The number of shares has decreased by -2.65% in one year.

Better Therapeutics’s return on equity (ROE) is 44.23 and return on invested capital (ROIC) is -273.67%.

The current PE Ratio of Better Therapeutics is ―. Better Therapeutics’s PEG ratio is 0.56.

In the last 12 months, Better Therapeutics had revenue of 0.00 and earned -39.76M in profits. Earnings per share was -1.69.

In the last 12 months, operating cash flow was -26.08M and capital expenditures -1.39M, giving a free cash flow of -27.47M billion.

Better Therapeutics pays an annual dividend of ―, resulting in a dividend yield of ―

Better Therapeutics upcoming earnings date is Nov 11, 2024, Before Open (Confirmed).

Better Therapeutics as a current ratio of 1.37, with Debt / Equity ratio of -1655.17%

In the past 12 months, Better Therapeutics has paid 7.00K in taxes.

Better Therapeutics EV to EBITDA ratio is -0.66, with an EV/FCF ratio of -0.84.

Better Therapeutics has $6.60M in cash and marketable securities with $14.31M in debt, giving a net cash position of -$7.71M billion.

Gross margin is 0.00%, with operating margin of 0.00%, and net profit margin of 0.00%.

The average price target for Better Therapeutics is ―, which is 11.43% higher than the current price. The consensus rating is ―